Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Stephen Brimijoin, Ph.D.

Back to Research Profile

  1. Gao Y, Brimijoin S. Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approach. J Pharmacol Exp Ther 2009 Aug; 330(2):449-57. Epub 2009 May 28.
    View PubMed
  2. Tang H, Pavel J, Saavedra JM, Brimijoin S. Type-1 angiotensin receptors are expressed and transported in motor and sensory axons of rat sciatic nerves. Neuropeptides 2009 Apr; 43(2):81-92. Epub 2009 Feb 23.
    View PubMed
  3. Brimijoin S, Gao Y, Anker JJ, Gliddon LA, Lafleur D, Shah R, Zhao Q, Singh M, Carroll ME. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology 2008 Oct; 33(11):2715-25. Epub 2008 Jan 16.
    View PubMed
  4. Gao Y, LaFleur D, Shah R, Zhao Q, Singh M, Brimijoin S. An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties. Chem Biol Interact 2008 Sep 25; 175(1-3):83-7. Epub 2008 May 01.
    View PubMed
  5. Tang H, Pavel J, Saavedra JM, Brimijoin S. Angiotensin II type 1 receptors may not influence response of spinal autonomic neurons to axonal damage. Neurol Res 2008 Sep; 30(7):751-60. Epub 2008 May 21.
    View PubMed
  6. Lassiter TL, Brimijoin S. Rats gain excess weight after developmental exposure to the organophosphorothionate pesticide, chlorpyrifos. Neurotoxicol Teratol 2008 Mar-Apr; 30(2):125-30. Epub 2007 Nov 06.
    View PubMed
  7. Brimijoin S. Neuroscience in China. Cell Mol Neurobiol 2008 Jan; 28(1):1-2. Epub 2007 Nov 14.
    View PubMed
  8. Tang H, Brimijoin S. Angiotensin II type-1 receptors may not influence response of spinal neurons to axonal damage Neurology Research 2008; 30:751-760.
    View PubMed
  9. Brimijoin S, Gao Y, Anker JJ, Gliddon LA, LaFleur D, Shah R, Zhao Q, Singh M, Carroll ME. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacol 2008; 33:2715-2725.
    View PubMed
  10. Garcia-Ayllon MS, Silveyra MX, Andreasen N, Brimijoin S, Blennow K, Saez-Valero J. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease. J Neurochem 2007 Jun; 101(6):1701-11. Epub 2007 Feb 26.
    View PubMed
  11. Lassiter TL, Brimijoin S. A method to determine precise benchmark doses for carbamate anticholinesterases. Toxicol Sci 2007 Mar; 96(1):154-61 Epub 2006 Dec 11.
    View PubMed
  12. Lassiter TL, Brimijoin S. Determining precise benchmark doses for carbamate anticholinesterases Toxicol Sci 2007; 96:154-161.
    View PubMed
  13. Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiol Dis 2006 Nov; 24(2):326-33. Epub 2006 Sep 14.
    View PubMed
  14. Gao Y, Brimijoin S. Viral transduction of cocaine hydrolase in brain reward centers. Cell Mol Neurobiol 2006 Jul-Aug; 26(4-6):357-63. Epub 2006 May 18.
    View PubMed
  15. Gao Y, Brimijoin S. Visualizing viral transduction of a cocaine-hydrolyzing, human butyrylcholinesterase in rats. Chem Biol Interact 2005 Dec 15; 157(Special Issue SI):97-103.
    View PubMed
  16. Rees TM, Berson A, Sklan EH, Younkin L, Younkin S, Brimijoin S, Soreq H. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr Alzheimer Res 2005 Jul; 2(3):291-300.
    View PubMed
  17. Brimijoin S. Can cholinesterase inhibitors affect neural development? Environmental Toxicology & Pharmacology 2005 May; 19(3 Special Issue SI):429-32.
  18. Gao Y, Atanasova E, Sui N, Pancook JD, Watkins JD, Brimijoin S. Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats. Mol Pharmacol 2005 Jan; 67(1):204-11.
    View PubMed
  19. Gao Y, Brimijoin S. An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats. J Pharmacol Exp Ther 2004 Sep; 310(3):1046-52.
    View PubMed
  20. Conti AM, Brimijoin S, Miller LJ, Windebank AJ. Suppression of neurite outgrowth by high-dose nerve growth factor is independent of functional p75NTR receptors. Neurobiol Dis 2004 Feb; 15(1):106-14.
    View PubMed
  21. Hammond PI, Kern C, Hong F, Kollmeyer TM, Pang YP, Brimijoin S. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design. J Pharmacol Exp Ther 2003 Oct 1; 307(1):190-6.
    View PubMed
  22. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 2003 Oct; 24(6):777-87.
    View PubMed
  23. Hu W, Gray NW, Brimijoin S. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem 2003 Jul; 86(2):470-8.
    View PubMed
  24. Pang YP, Kollmeyer TM, Hong F, Lee JC, Hammond PI, Haugabouk SP, Brimijoin S. Rational design of alkylene-linked bis-pyridiniumalidoximes as improved acetylcholinesterase reactivators. Chem Biol 2003 Jun; 10(6):491-502.
    View PubMed
  25. Leelakusolvong S, Bharucha AE, Sarr MG, Hammond PI, Brimijoin S, Phillips SF. Effect of extrinsic denervation on muscarinic neurotransmission in the canine ileocolonic region. Neurogastroenterol Motil 2003 Apr; 15(2):173-86.
    View PubMed
  26. Hammond PI, Craig TA, Kumar R, Brimijoin S. Regional and cellular distribution of DREAM in adult rat brain consistent with multiple sensory processing roles. Mol Brain Res 2003 Mar 17; 111(1-2):104-10.
    View PubMed
  27. Rees TM, Brimijoin S. The role of acetylicholinesterase in the pathogenesis of Alzheimer's disease. Drugs of Today 2003 Jan; 39(1):75-83.
    View PubMed
  28. Zhang H, Brimijoin S, Tang X-C. Apoptosis by β-amyloid25-35 in acetylcholine-esterase-overexpressing neuroblastoma cells. Acta Pharmacol Sinica 2003; 24:853-858.
    View PubMed
  29. Brimijoin S, Shen ML, Sun H. Radiometric solvent-partitioning assay for screening cocaine hydrolases and measuring cocaine levels in milligram tissue samples. Anal Biochem 2002 Oct 15; 309(2):200-5.
    View PubMed
  30. Tang H, Brimijoin S. Death of preganglionic sympathetic neurons after surgical or immunologic lesion of peripheral processes. Exp Neurol 2002 Sep; 177(1):105-14.
    View PubMed
  31. Sun H, Shen ML, Pang YP, Lockridge O, Brimijoin S. Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J Pharmacol Exp Ther 2002 Aug; 302(2):710-6.
    View PubMed
  32. Sun H, Pang YP, Lockridge O, Brimijoin S. Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol Pharmacol 2002 Aug; 62(2):220-4.
    View PubMed
  33. Tang H, Brimijoin S. Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody. J Neuroimmunol 2001 Apr 2; 115(1-2):53-63.
    View PubMed
  34. Sun H, El Yazal J, Lockridge O, Schopfer LM, Brimijoin S, Pang YP. Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase. Engineering effective butyrylcholinesterase mutants for cocaine detoxication. J Biol Chem 2001 Mar 23; 276(12):9330-6.
    View PubMed
  35. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, Brimijoin S, Hinrichs S, Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 2001; 75:1320-1331.
    View PubMed
  36. Sharma KV, Brimijoin S, Koenigsberger C, Bigbee J. Acetylcholinesterase modulates the adhesion of neuroblastoma cells. J Neurosci Res , 2001; 63:165-175.
    View PubMed
  37. Atanasova E, Chiappa S, Wieben E, Brimijoin S. Novel messenger RNA and alternative promoter for murine acetylcholinesterase. J Biol Chem 1999 Jul 23; 274(30):21078-84.
    View PubMed
  38. Tang H, Miller SM, Ermilov LG, Lennon VA, Brimijoin S. Complement-mediated lesion of sympathetic ganglia in vitro with acetylcholinesterase antibodies. J Neuroimmunol 1999 Jun 1; 97(1-2):86-93.
    View PubMed
  39. Veenstra TD, Prufer K, Koenigsberger C, Brimijoin SW, Grande JP, Kumar R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res 1998 Sep 7; 804(2):193-205.
    View PubMed
  40. Pang YP, Brimijoin S. Supercomputing-based dimeric analog approach for drug optimization. Parallel Comput 1998 Sep; 24(9-10):1557-1566.
    View PubMed
  41. Tang H, Hammond P, Brimijoin S. Acetylcholinesterase immunolesioning: regional vulnerability of preganglionic sympathetic neurons in rat spinal cord. Exp Neurol 1998 Aug; 152(2):167-76.
    View PubMed
  42. Koenigsberger C, Hammond P, Brimijoin S. Developmental expression of acetyl- and butyrylcholinesterase in the rat: enzyme and mRNA levels in embryonic dorsal root ganglia. Brain Res 1998 Mar 23; 787(2):248-58.
    View PubMed
  43. Mortensen SR, Brimijoin S, Hooper MJ, Padilla S. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol Appl Pharmacol 1998 Jan; 148(1):46-9.
    View PubMed
  44. Mortensen SR, Brimijoin S, Hooper MJ, Padilla S. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol Appl Pharmacol 1998 Jan; 148(1):46-9.
    View PubMed
  45. Veenstra TD, Prüfer K, Koenigsberger C, Brimijoin S, Kumar R. Immunolocalization of the 1,25-dihydroxyvitamin D3 receptor in the central nervous system of the rat embryo. Brain Res 1998; 804:193-205.
    View PubMed
  46. Miller SM, Ermilov LG, Szurszewski JH, Hammond PI, Brimijoin S. Selective disruption of neurotransmission by acetylcholinesterase antibodies in sympathetic ganglia examined with intracellular microelectrodes. J Auton Nerv Syst 1997 Dec 11; 67(3):156-67.
    View PubMed
  47. Koenigsberger C, Chiappa S, Brimijoin S. Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression. J Neurochem 1997 Oct; 69(4):1389-97.
    View PubMed
  48. Veenstra TD, Londowski JM, Windebank AJ, Brimijoin S, Kumar R. Effects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells. Brain Res Dev Brain Res 1997 Mar 17; 99(1):53-60.
    View PubMed
  49. Pang YP, Hong F, Quiram P, Jelacic T, Brimijoin S. Synthesis of alkylene linked bis-THA and alkylene linked benzyl-THA as highly potent and selective inhibitors and molecular probes of acetylcholinesterase. J Chem Soc Perkin Trans 1 1997 Jan 21(2):171-6..
    View PubMed
  50. Holgert H, Holmberg K, Hannibal J, Fahrenkrug J, Brimijoin S, Hartman BK, Hokfelt T. PACAP in the adrenal gland--relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport 1996 Dec 20; 8(1):297-301.
    View PubMed
  51. Holgert H, Lagercrantz H, Dagerlind A, Hartman BK, Cozzari C, Brimijoin S, Hokfelt T. Effects of immunological sympathectomy on postnatal peptide expression in the rat adrenal medulla. Brain Res Dev Brain Res 1996 Nov 22; 97(1):88-95.
    View PubMed
  52. Hammond PI, Jelacic T, Padilla S, Brimijoin S. Quantitative, video-based histochemistry to measure regional effects of anticholinesterase pesticides in rat brain. Anal Biochem 1996 Oct 1; 241(1):82-92.
    View PubMed
  53. Pang YP, Quiram P, Jelacic T, Hong F, Brimijoin S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem 1996 Sep 27; 271(39):23646-9.
    View PubMed
  54. Wilson BW, Padilla S, Henderson JD, Brimijoin S, Dass PD, Elliot G, Jaeger B, Lanz D, Pearson R, Spies R. Factors in standardizing automated cholinesterase assays. J Toxicol Environ Health 1996 Jun 7; 48(2):187-95.
    View PubMed
  55. McKinzie S, Tyce GM, Brimijoin S. Lowered norepinephrine turnover as a sign of impaired ganglionic transmission after preganglionic lesioning by acetylcholinesterase antibodies. J Pharmacol Exp Ther 1996 May; 277(2):817-22.
    View PubMed
  56. Pang Y-P, Quiram P, Jelacic T, Hong F, Brimijoin S. Highly potent selective, selective, and low-cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase: a new generation of drugs for cholinergic therapy of Alzheimer's disease. J Biol Chem 1996; 271:23646-49.
    View PubMed
  57. Brimijoin S, Hammond P. Transient expression of acetylcholinesterase mRNA and enzyme activity in developing rat thalamus studied by quantitative histochemistry and in situ hybridization. Neurosci 1996; 71:555-565.
    View PubMed
  58. Carmichael SW, Brimijoin WS. Looking at slow axonal transport. Microscopy Today 1996; 96(9):3.
  59. Holgert H, Åman K, Cozzari C, Hartman BK, Brimijoin S, Emson P, Goldstein M, Hökfelt T. The cholinergic innervation of the adrenal gland and its relation to enkephalin and nitric oxide synthase. Neuroreport 1995 Dec 15; 6(18):2576-80.
    View PubMed
  60. Brimijoin WS. Using antibodies to unwire the sympathetic nervous system. News Physiol Sci 1995 Jun; 10:101-106.
    View PubMed
  61. Bruss M, Hammermann R, Brimijoin S, Bonisch H. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 1995 Apr 21; 270(16):9197-201.
    View PubMed
  62. Russell JW, Windebank AJ, McNiven MA, Brat DJ, Brimijoin WS. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res 1995 Apr 10; 676(2):258-67.
    View PubMed
  63. Russell JW, Windebank AJ, McNiven MA, Brat DJ, Brimijoin WS. Effect of cisplatin and ACTH (4-9) on neural transport in cisplatin induced neurotoxicity. Brain Res 1995 Apr 10; 676:258-67.
    View PubMed
  64. Li W, Ochalski PA, Brimijoin S, Jordan LM, Nagy JI. C-terminals on motoneurons: electron microscope localization of cholinergic markers in adult rats and antibody-induced depletion in neonates. Neuroscience 1995 Apr; 65(3):879-91.
    View PubMed
  65. Chiappa S, Padilla S, Koenigsberger C, Moser V, Brimijoin S. Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochem Pharmacol 1995 Mar 30; 49(7):955-63.
    View PubMed
  66. Chiappa S, Padilla S, Koenigsberger C, Moser V, Brimijoin S. Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochem Pharmacol 1995 Mar 30; 49(7):955-63.
    View PubMed
  67. Brimijoin S, Dagerlind A, Rao R, McKinzie S, Hammond P. Accumulation of enkephalin, proenkephalin mRNA, and neuropeptide Y in immunologically denervated rat adrenal glands: evidence for divergent peptide regulation. J Neurochem 1995 Mar; 64(3):1281-7.
    View PubMed
  68. Rao R, Brimijoin S. Reverse transcriptase-polymerase chain reaction assay for acetylcholinesterase mRNA in rat brain. Neurochem Res 1995 Feb; 20(2):129-35.
    View PubMed
  69. Li W, Ochalski PAY, Brimijoin S, Jordan LM, Nagy JI C. Terminals on motoneurons: EM localization of cholinergic markers in adult rats and antibody-induced depletion in neonates. Neuroscience 1995; 65:879-891.
    View PubMed
  70. Brimijoin S, Dagerlind Å, Hammond P. Accumulation of enkephalin and neuropeptide Y in the rat adrenal gland after antibody-mediated splanchnic denervation: evidence for divergent peptide regulation. J Neurochem 1995; 64:1281-1287.
    View PubMed
  71. Holgert H, Åman K, Cozzari C, Hartman BK, Brimijoin S, Emson P, Goldstein M, Hökfelt, T. The cholinergic innervation of the adrenal gland and its relation to enkephalin and nitric oxide synthase. NeuroReport 1995; 6:2576-2580.
    View PubMed
  72. Hammond P, Rao R, Koenigsberger C, Brimijoin S. Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization. Proc Natl Acad Sci U S A 1994 Nov 8; 91(23):10933-7.
    View PubMed
  73. Mesulam MM, Brimijoin S, Geula C. Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons. Neurobiol Aging 1994 Sep-Oct; 15(5):615-9.
    View PubMed
  74. Dagerlind A, Pelto-Huikko M, Lundberg JM, Ubink R, Verhofstad A, Brimijoin S, Hokfelt T. Immunologically induced sympathectomy of preganglionic nerves by antibodies against acetylcholinesterase: increased levels of peptides and their messenger RNAs in rat adrenal chromaffin cells. Neuroscience 1994 Sep; 62(1):217-39.
    View PubMed
  75. Brimijoin S, Hammond P, Khraibi AA, Tyce GM. Catecholamine release and excretion in rats with immunologically induced preganglionic sympathectomy. J Neurochem 1994 Jun; 62(6):2195-204.
    View PubMed
  76. Dagerlind A, Zhang X, Brimijoin S, Lindh B, Hokfelt T. Effects of preganglionic sympathectomy on peptides in the rat superior cervical ganglion. Neuroreport 1994 Apr 14; 5(8):909-12.
    View PubMed
  77. Oka N, Brimijoin S. Altered spectrum of retrogradely transported axonal proteins in P-bromophylacetylurea neuropathy. Neurochem Res 1993 Jun; 18:675-680.
    View PubMed
  78. Dagerlind A, Brimijoin S, Goldstein M, Hokfelt T. Effects of antibodies against acetylcholinesterase on the expression of peptides and catecholamine synthesizing enzymes in the rat adrenal gland. Neuroscience 1993 Jun; 54:1079-1090.
    View PubMed
  79. Brat DJ, Brimijoin S. Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy. J Neurochem 1993 Jun; 60(6):2145-52.
    View PubMed
  80. Rakonczay Z, Hammond P, Brimijoin S. Lesion of central cholinergic systems by systemically administered acetylcholinesterase antibodies in newborn rats. Neuroscience 1993 May; 54(1):225-38.
    View PubMed
  81. Brimijoin S, Moser V, Hammond P, Oka N, Lennon VA. Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience 1993 May; 54(1):201-23.
    View PubMed
  82. Oka N, Brimijoin S. Altered spectrum of retrogradely transported axonal proteins in p-arabromophenylacetylurea neuropathy. J Neurosci Res 1993; 18:675-680.
    View PubMed
  83. Dagerlind Å, Brimijoin S, Goldstein M, Hökfelt T. Effects of antibodies against acetylcholinesterase on the expression of peptides and catecholamine synthesizing enzymes in the rat adrenal gland. Neuroscience 1993; 54:1079-1090.
    View PubMed
  84. Brat DJ, Brimijoin S. A paradigm for examining toxicant effects on viability, structure, and axonal transport of neurons in culture. Mol Neurobiol 1992 Summer-Fall; 6(2-3):125-35.
    View PubMed
  85. Brat DJ, Windebank AJ, Brimijoin S. Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma. J Pharmacol Exp Ther 1992 May; 261(2):803-10.
    View PubMed
  86. Oka N, Brimijoin WS. Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography. Mayo Clin Proc 1992 Apr; 67(4):341-8.
    View PubMed
  87. Oka N, Brimijoin WS. Tubulomembranous lesions in para-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography. Mayo Clin Proc 1992 Apr; 67(4):341-8.
    View PubMed
  88. Padilla S, Moser VC, Pope CN, Brimijoin WS. Paraoxon toxicity is not potentiated by prior reduction in blood acetylcholinesterase. Toxicol Appl Pharmacol 1992; 117:110-115.
    View PubMed
  89. Padilla S, Moser VC, Pope CN, Brimijoin S. Paraoxon toxicity is not potentiated by prior reduction in blood acetylcholinesterase. Toxicol Appl Pharmacol 1992; 117:110-115.
    View PubMed
  90. Bean AJ, Xu Z, Chai SY, Brimijoin S, Hokfelt T. Effect of intracerebral injection of monoclonal acetylcholinesterase antibodies on cholinergic nerve terminals in the rat central nervous system. Neurosci Lett 1991 Nov 25; 133(1):145-9.
    View PubMed
  91. Mesulam MM, Geula C, Cosgrove R, Mash D, Brimijoin S. Immunocytochemical demonstration of axonal and perikaryl in human cerebral cortex. Brain Res 1991 Jan 25; 539:233-238.
    View PubMed
  92. Mesulam M-M, Geula C, Cosgrove R, Mash D, Brimijoin S. Immunocytochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral neocortex. Brain Res 1991; 539:233-238.
    View PubMed
  93. Brimijoin S, Lennon VA. Selective destruction of preganglionic sympathetic nerves by antibodies to acetylcholinesterase. J Neural Transm Suppl 1991; 34:139-45.
    View PubMed
  94. Brimijoin S, Lennon VA. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc Natl Acad Sci U S A 1990 Dec; 87(24):9630-4.
    View PubMed
  95. Oka N, Brimijoin S. Premature onset of fast axonal transport in bromophenylacetylurea neuropathy: an electrophoretic analysis of proteins exported into motor nerve. Brain Res 1990 Feb 12; 509(1):107-10.
    View PubMed
  96. Brimijoin S, Balm M, Hammond P, Lennon VA. Selective complexing of acetylcholinesterase in brain by intravenously administered monoclonal antibody. J Neurochem 1990 Jan; 54(1):236-41.
    View PubMed
  97. Studelska DR, Brimijoin S. Partial isolation of two classes of dopamine beta-hydroxylase-containing particles undergoing rapid axonal transport in rat sciatic nerve. J Neurochem 1989 Aug; 53(2):622-31.
    View PubMed
  98. Studelska DR, Brimijoin S. Partial isolation of two classes of DBH-containing particles undergoing rapid axonal transport in rat sciatic nerve. J Neurochem 1989; 53:622-631.
    View PubMed
  99. Brimijoin S, Hammond P. Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay. J Neurochem 1988 Oct; 51:1227-1231.
    View PubMed
  100. Brimijoin S, Hammond P. Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay. J Neurochem 1988 Oct; 51(4):1227-31.
    View PubMed
  101. Nelson DK, Service JE, Studelska DR, Brimijoin S, Go VL. Gastrointestinal neuropeptide concentrations following guanethidine sympathectomy. J Auton Nerv Syst 1988 Apr; 22(3):203-10.
    View PubMed
  102. Hammond P, Brimijoin S. Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions. J Neurochem 1988 Apr; 50(4):1111-6.
    View PubMed
  103. Nagata H, Brimijoin S, Low P, Schmelzer JD. Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea. Brain Res 1987 Oct 6; 422(2):319-26.
    View PubMed
  104. Brimijoin S, Hammond P, Rakonczay Z. Two-site immunoassay for acetylcholinesterase in brain, nerve, and muscle. J Neurochem 1987 Aug; 49(2):555-62.
    View PubMed
  105. Brimijoin S, Rakonczay ZR, Hammond P. Immunoassay of acetylcholinesterase. Fed Proc 1987 Jun; 46(8):2557-62.
    View PubMed
  106. Pfeiffer GL, Brimijoin S, Studelska DR, Carmichael S. Electron microscopy of isolated mitochondrion-chromaffin vesicle complexes. Z Mikrosk -Anat Forsch , 1987; 101:S567-S576.
    View PubMed
  107. Pfeiffer GL, Brimijoin WS, Studelska DR, Carmichael SW. Electron microscopy of isolated mitochondrion-chromaffin vesicle complexes. Z Mikrosk Anat Forsch 1987; 101(4):567-76.
    View PubMed
  108. Brimijoin S, Rakonczay Z, Mintz K. Immunochemistry of mammalian cholinesterases. Fed Proc 1986 Dec; 45(13):2960-4.
    View PubMed
  109. Nagata H, Brimijoin S. Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport. Brain Res 1986 Oct 15; 385(1):136-42.
    View PubMed
  110. Nagata H, Brimijoin S. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea. Ann Neurol 1986 May; 19(5):458-64.
    View PubMed
  111. Rakonczay Z, Brimijoin S. Monoclonal antibodies to rat brain acetylcholinesterase: comparative affinity for soluble and membrane-associated enzyme and for enzyme from different vertebrate species. J Neurochem 1986 Jan; 46(1):280-7.
    View PubMed
  112. Brimijoin S, Hammond P, Petitt R. Paroxysmal nocturnal hemoglobinuria: Red cell acetylcholinesterase deficit analyzed by immunoassay and fluorescence-activated sorting. Mayo Clinic Proc 1986; 61:522-529.
    View PubMed
  113. Brimijoin S, Rakonczay Z. Immunology and molecular biology of the cholinesterases: current results and prospects. Int Rev Neurobiol 1986; 28:363-410.
    View PubMed
  114. Brimijoin S, Mintz KP, Prendergast FG. An inhibitory monoclonal antibody to rabbit brain acetylcholinesterase. Studies on interaction with the enzyme. Mol Pharmacol 1985 Dec; 28(6):539-45.
    View PubMed
  115. Rakonczay Z, Brimijoin S. Immunochemical differences among molecular forms of acetylcholinesterase in brain and blood. Biochim Biophys Acta 1985 Nov 29; 832(2):127-34.
    View PubMed
  116. Mintz KP, Brimijoin S. Monoclonal antibodies to rabbit brain acetylcholinesterase: selective enzyme inhibition, differential affinity for enzyme forms, and cross- reactivity with other mammalian cholinesterases. J Neurochem 1985 Jul; 45(1):284-92.
    View PubMed
  117. Brimijoin S, Mintz KP. Human acetylcholinesterase. Immunochemical studies with monoclonal antibodies. Biochim Biophys Acta 1985 Apr 29; 828(3):290-7.
    View PubMed
  118. Low PA, Ward K, Schmelzer JD, Brimijoin S. Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am J Physiol 1985 Apr; 248(4 Pt 1):E457-62.
    View PubMed
  119. Studelska DR, Campbell NR, Brimijoin WS. Catecholamine binding by adrenal medullary protein can interfere with a sensitive radioenzymatic assay for norepinephrine. Life Sci 1985 Mar 4; 36(9):881-7.
    View PubMed
  120. Studelska DR, Campbell NR, Brimijoin WS. Catecholamine binding by adrenal medullary protein can interfere with a sensitive radioenzymatic assay for norepinephrine. Life Sci 1985 Mar 4; 36(9):881-7.
    View PubMed
  121. Brimijoin WS, Hammond PI. Acrylamide neuropathy in the rat: effects on energy metabolism in sciatic nerve. Mayo Clin Proc 1985 Jan; 60(1):3-8.
    View PubMed
  122. Mintz KP, Brimijoin S. Two-step immunoaffinity purification of acetylcholinesterase from rabbit brain. J Neurochem 1985 Jan; 44(1):225-32.
    View PubMed
  123. Brimijoin S, Hammond P. Acrylamide neuropathy in the rat: Effects on sciatic nerve energy metabolism. Mayo Clinic Proc 1985; 60:3-8.
    View PubMed
  124. Rakonczay Z, Brimijoin S. Monoclonal antibodies to human brain acetylcholinesterase: properties and applications. Cell Mol Neurobiol 1985; 8:85-93.
    View PubMed
  125. Brimijoin S, Mintz KP. Unimpaired energy metabolism in experimental neuropathy induced by P-bromophenylacetylurea. Muscle Nerve 1984 Nov/Dec; 7:725-732.
    View PubMed
  126. Brimijoin S, Mintz KP. Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea. Muscle Nerve 1984 Nov-Dec; 7(9):725-32.
    View PubMed
  127. Mintz KP, Weinshilboum R, Brimijoin S. Evolution of butyrylcholinesterase in higher primates: An immunochemical study. Comp Biochem Physiol 1984; 79C:35-37.
    View PubMed
  128. Mintz KP, Weinshilboum RM, Brimijoin WS. Evolution of butyrylcholinesterase in higher primates: an immunochemical study. Comp Biochem Physiol C 1984; 79(1):35-7.
    View PubMed
  129. Brimijoin S, Mintz KP, Alley MC. Production and characterization of separate monoclonal antibodies to human acetylcholinesterase and butyrylcholinesterase. Mol Pharmacol 1983 Nov; 24(3):513-20.
    View PubMed
  130. Litchy WJ, Brimijoin S. Concentration dependence of rapid axonal transport: a study of the transport kinetics of [35S]methionine-labeled protein in postganglionic sympathetic fibers of the bullfrog. J Neurosci 1983 Oct; 3(10):2075-82.
    View PubMed
  131. Dyck PJ, Mellinger JF, Reagan TJ, Horowitz SJ, McDonald JW, Litchy WJ, Daube JR, Fealey RD, Go VLW, Kao PC, Brimijoin WS, Lambert EH. Not 'indifference to pain', but varieties of hereditary, sensory, and autonomic neuropathy. Brain 1983 Jun; 106(PART II):373-390.
    View PubMed
  132. Edwards JA, Brimijoin S. Effects of hypophysectomy on acetylcholinesterase and butyrylcholinesterase in the rat. Biochem Pharmacol 1983 Apr 1; 32(7):1183-9.
    View PubMed
  133. Edwards JA, Brimijoin S. Thermal inactivation of the molecular forms of acetylcholinesterase and butyrylcholinesterase. Biochim Biophys Acta 1983 Feb 15; 742(3):509-16.
    View PubMed
  134. Brimijoin S, Mintz KP, Prendergast FG. Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase. Biochem Pharmacol 1983 Feb 15; 32(4):699-706.
    View PubMed
  135. Jakobsen J, Brimijoin S, Sidenius P. Axonal transport in neuropathy. Muscle Nerve 1983 Feb; 6(2):164-6.
    View PubMed
  136. Brimijoin S. Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol 1983; 21(4):291-322.
    View PubMed
  137. Dyck PJ, Mellinger JF, Reagen TJ, Horowitz SJ, McDonald JW, Litchy WJ, Daube JR, Fealey RD, Go VL, Kao PC, Brimijoin S, Lambert EH. Not "indifference to pain" but varieties of hereditary sensory and autonomic neuropathy. Brain 1983; 106:373-390.
    View PubMed
  138. Brimijoin WS. Abnormalities of axonal transport: are they a cause of peripheral nerve disease? Mayo Clin Proc 1982 Nov; 57(11):707-14.
    View PubMed
  139. Brimijoin S, Schreiber PA. Reduced axonal transport of 10S acetylcholinesterase in dystrophic mice. Muscle Nerve 1982 May-Jun; 5(5):405-10.
    View PubMed
  140. Brimijoin S. Microtubules and the capacity of the system for rapid axonal transport. Fed Proc 1982 May; 41(7):2312-6.
    View PubMed
  141. Edwards JA, Brimijoin S. Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat. J Neurochem 1982 May; 38(5):1393-403.
    View PubMed
  142. Carter J, Lennon VA, Schreiber P, Brimijoin S. Content and release of acetylcholinesterase in skeletal muscle of rats with experimental autoimmune myasthenia gravis. Exp Neurol 1982 Feb; 75(2):490-500.
    View PubMed
  143. Brimijoin S, Carter J. Turnover of the molecular forms of acetylcholinesterase in the rat diaphragm. J Neurochem 1982 Feb; 38(2):588-90.
    View PubMed
  144. Jakobsen J, Lambert EH, Carlson G, Brimijoin S. Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea. Exp Neurol 1982 Jan; 75(1):158-72.
    View PubMed
  145. Brimijoin S, Carlson G, Nguyen NN, Jakobsen J. Analogs of p-bromophenylacetylurea: a structure activity study of their neurotoxicity in rats. Muscle Nerve 1982; 5(9S):S122-6.
    View PubMed
  146. Brimijoin S. Abnormalities of axonal transport: Are they a cause of peripheral nerve disease? Mayo Clinic Proc 1982; 57:707-714.
    View PubMed
  147. Jakobsen J, Brimijoin S. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea. Brain Res 1981 Dec 14; 229(1):103-22.
    View PubMed
  148. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D. Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981 Oct; 30(10):797-803.
    View PubMed
  149. Skau KA, Brimijoin S. Abnormal distribution of skeletal muscle acetylcholinesterase molecular forms in dystrophic mice. Exp Neurol 1981 Oct; 74(1):111-21.
    View PubMed
  150. Lundberg JM, Fahrenkrug J, Brimijoin S. Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat. Acta Physiol Scand 1981 Aug; 112(4):427-36.
    View PubMed
  151. Cater JL, Brimijoin S. Effects of acute and chronic denervation on release of acetylcholinesterase and its molecular forms in rat diaphragms. J Neurochem 1981 Mar; 36(3):1018-25.
    View PubMed
  152. Skau KA, Brimijoin S. Multiple molecular forms of acetylcholinesterase in rat vagus nerve, smooth muscle, and heart. J Neurochem 1980 Nov; 35(5):1151-4.
    View PubMed
  153. Evans BA, Yao JK, Holman RT, Brimijoin WS, Lambert EH, Dyck PJ. Structural and biochemical effects of essential fatty acid deficiency on peripheral nerve. J Neuropathol Exp Neurol 1980 Nov; 39(6):683-91.
    View PubMed
  154. Brimijoin S, Lundberg JM, Brodin E, Hokfelt T, Nilsson G. Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig. Brain Res 1980 Jun 9; 191(2):443-57.
    View PubMed
  155. Lundberg JM, Hokfelt T, Anggard A, Uvnas-Wallensten K, Brimijoin S, Brodin E, Fahrenkrug J. Peripheral peptide neurons: distribution, axonal transport, and some aspects on possible function. Adv Biochem Psychopharmacol 1980; 22:25-36.
    View PubMed
  156. Brimijoin S, Dyck PJ. Axonal transport of dopamine-beta-hydroxylase and acetylcholinesterase in human peripheral neuropathy. Exp Neurol 1979 Dec; 66(3):467-78.
    View PubMed
  157. Dyck PJ, Carney JA, Sizemore GW, Okazaki H, Brimijoin WS, Lambert EH. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol 1979 Oct; 6(4):302-14.
    View PubMed
  158. Dyck PJ, Carney JA, Sizemore GW, Okazaki H, Brimijoin WS, Lambert EH. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol 1979 Oct; 6(4):302-14.
    View PubMed
  159. Brimijoin S. On the kinetics and maximal capacity of the system for rapid axonal transport in mammalian neurones. J Physiol (Lond) 1979 Jul; 292:325-37.
    View PubMed
  160. Brimijoin S. Axonal transport and subcellular distribution of molecular forms of acetylcholinesterase in rabbit sciatic nerve. Mol Pharmacol 1979 May; 15(3):641-8.
    View PubMed
  161. Starkey RR, Brimijoin S. Stop-flow analysis of the axonal transport of dopa decarboxylase (EC 4.1.1.26) in rabbit sciatic nerves. J Neurochem 1979 Feb; 32(2):437-41.
    View PubMed
  162. Brimijoin S, Olsen J, Rosenson R. Comparison of the temperature-dependence of rapid axonal transport and microtubules in nerves of the rabbit and bullfrog. J Physiol (Lond) 1979 Feb; 287:303-14.
    View PubMed
  163. Brimijoin S, Skau K, Wiermaa MJ. On the origin and fate of external acetylcholinesterase in peripheral nerve. J Physiol (Lond) 1978 Dec; 285:143-58.
    View PubMed
  164. Brimijoin S, Wiermaa MJ. Rapid orthograde and retrograde axonal transport of acetylcholinesterase as characterized by the stop-flow technique. J Physiol (Lond) 1978 Dec; 285:129-42.
    View PubMed
  165. Skau KA, Brimijoin S. Release of acetylcholinesterase from rat hemidiaphragm preparations stimulated through the phrenic nerve. Nature 1978 Sep 21; 275(5677):224-6.
    View PubMed
  166. Brimijoin S, Wiermaa MJ. Direct comparison of the rapid axonal transport of norepinephrine and dopamine-beta-hydroxylase activity. J Neurobiol 1977 May; 8(3):239-50.
    View PubMed
  167. Brimijoin S. A histofluorescence study of events accompanying accumulation and migration of norepinephrine within locally cooled nerves. J Neurobiol 1977 May; 8(3):251-63.
    View PubMed
  168. Brimijoin S, Wiermaa MJ. Rapid axonal transport of tyrosine hydroxylase in rabbit sciatic nerves. Brain Res 1977 Jan 31; 121(1):77-96.
    View PubMed
  169. Ohnishi A, Schilling K, Brimijoin WS, Lambert EH, Fairbanks VF, Dyck PJ. Lead neuropathy: 1. Morphometry, nerve conduction, and choline acetyltransferase transport: new finding of endoneurial edema associated with segmental demyelination. J Neuropathol Exp Neurol 1977; 36:499-518.
    View PubMed
  170. Ohnishi A, Schilling K, Brimijoin S, Lambert EH, Fairbanks VF, Dyck PJ. Lead neuropathy: 1) morphometry, nerve conduction, and choline acetyltransferase transport: New finding of endoneurial edema associated with segmental demyelination. J Neuropathol Exp Neurol 1977; 36:499-518.
    View PubMed
  171. Cosens B, Thacker D, Brimijoin S. Temperature-dependence of rapid axonal transport in sympathetic nerves of the rabbit. J Neurobiol 1976 Jul; 7(4):339-54.
    View PubMed
  172. Brimijoin S, Helland L. Rapid retrograde transport of dopamine-beta-hydroxylase as examined by the stop-flow technique. Brain Res 1976 Feb 6; 102(2):217-28.
    View PubMed
  173. Brimijoin S. Cycloheximide alters axonal transport and subcellular distribution of dopamine-beta-hydroxylase activity. J Neurochem 1976 Jan; 26(1):35-40.
    View PubMed
  174. Brimijoin S, Jablecki C. Reduced axonal transport of dopamine-beta-hydroxylase in dystrophic mice: evidence for abnormality of adrenergic nerve cells. Exp Neurol 1976; 53:454-464.
    View PubMed
  175. Brimijoin S, Jablecki C. Reduced axonal transport of dopamine-beta-hydroxylase in dystrophic mice: evidence for abnormality of adrenergic nerve cells. Exp Neurol 1976; 53:454-464.
    View PubMed
  176. Jablecki C, Brimijoin S. Axoplasmic transport of choline acetyltransferase activity in mice: effect of age and neurotomy. J Neurochem 1975 Nov; 25(5):583-93.
    View PubMed
  177. Brimijoin S. Stop-flow: a new technique for measuring axonal transport, and its application to the transport of dopamine-beta-hydroxylase. J Neurobiol 1975 Jul; 6(4):379-94.
    View PubMed
  178. Jablecki C, Brimijoin S. Reduced axoplasmic transport of choline acetyltransferase activity in dystrophic mice. Nature 1974 Jul 12; 250(462):151-4.
    View PubMed
  179. Brimijoin S. Local changes in subcellular distribution of dopamine-beta-hydroxylase (EC 1.14.2.1) after blockade of axonal transport. J Neurochem 1974 Mar; 22(3):347-53.
    View PubMed
  180. Brimijoin WS. Evidence that 6-hydroxydopamine decreases synthesis of dopamine-beta-hydroxylase in sympathetic ganglia. J Pharmacol Exp Ther 1972 Nov; 183:298-306.
    View PubMed
  181. Brimijoin WS. Transport and turnover of dopamine-beta-hydroxylase (EC 1.14.2.1) in sympathetic nerves of the rat. J Neurochem 1972 Sep; 19:2183-93.
    View PubMed
  182. Molinoff PB, Brimijoin WS, Axelrod J. Induction of dopamine-beta-hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther 1972 Jul; 182:116-29.
    View PubMed
  183. Silberstein SD, Lemberger L, Brimijoin WS, Molinoff PB. Induction of dopamine-beta-hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem 1972 Mar; 19:919-21.
    View PubMed
  184. Silberstein SD, Lemberger L, Brimijoin S, Molinoff PB. Induction of dopamine-beta-hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem 1972; 19:919-921.
    View PubMed
  185. Molinoff PB, Brimijoin S, Axelrod J. Induction of dopamine-beta-hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther 1972; 182:116-129.
    View PubMed
  186. Brimijoin S. Evidence that 6-hydroxydopamine decreases synthesis of dopamine-beta-hydroxylase in sympathetic ganglia. J Pharmacol Exp Ther 1972; 183:298-306.
    View PubMed
  187. Brimijoin S. Transport and turnover of dopamine-beta hydroxylase in sympathetic nerves of the rat. J Neurochem 1972; 19:2183-2193.
    View PubMed
  188. Brimijoin S, Molinoff PB. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine- -hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther 1971 Sep; 178(3):417-24.
    View PubMed
  189. Brimijoin S, Trendelenburg U. Reserpine-induced release of norepinephrine from isolated spontaneously beating guinea-pig atria. J Pharmacol Exp Ther 1971 Jan; 176(1):149-59.
    View PubMed
  190. Brimijoin S, Molinoff PB, Axelrod. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine-beta-hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther 1971; 178:417-424.
    View PubMed
  191. Brimijoin S, Pluchino S, Trendelenburg U. On the mechanism of supersensitivity to norepinephrine in the denervated cat spleen. J Pharmacol Exp Ther 1970 Nov; 175(2):503-13.
    View PubMed
  192. Molinoff PB, Brimijoin S, Weinshilboum R, Axelrod J. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A 1970 Jun; 66(2):453-8.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.